Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

NCT06404047 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06404047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06404047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
July 17, 2024
Completion date
October 30, 2025
Enrollment
660 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, long covid-19, long covid19